Skip to main content
. Author manuscript; available in PMC: 2010 Sep 1.
Published in final edited form as: Hepatology. 2009 Sep;50(3):808–814. doi: 10.1002/hep.23082

TABLE 5.

Models

Hazard Ratio
(UDCA vs
placebo)		 (95% CI) P-Value
Adjusted for stratification variables: Mayo Risk Score, Baseline presence of
Varices, and Histologic Stage
    Primary Endpoints: (see figure 2) 2.27 (1.24, 4.16) 0.008
    Death, Liver Transplant or Minimal Criteria for Listing: (see figure 3) 2.11 (1.04, 4.28) 0.038
Adjusted for Mayo risk score, varices, histologic stage, age, gender, inflammatory
bowel disease, alkaline phosphatase, AST, and bilirubin.
    Primary Endpoints: 2.73 (1.37, 5.38) 0.004
    Death, Liver Transplant or Minimal Criteria for Listing: 2.85 (1.26, 6.49) 0.012